Surgery Partners Reports Mixed 2025 Results, Announces $200M Share Buyback
Event summary
- Surgery Partners reported a 6.2% revenue increase for full-year 2025, but Q4 results missed expectations with a $15M net loss.
- Same-facility revenues grew 4.9% for the year, while surgical cases increased 2.0%.
- Adjusted EBITDA rose 3.5% to $526.2M for the year, but declined 4.2% in Q4.
- The company set 2026 guidance for Adjusted EBITDA of at least $530M and revenue between $3.35B and $3.45B.
- Board authorized a $200M share repurchase program on February 26, 2026.
The big picture
Surgery Partners' mixed 2025 results reflect broader challenges in the healthcare services sector, including margin pressures and shifting payor dynamics. The company's focus on higher-acuity procedures and strategic M&A aligns with industry trends toward value-based care and consolidation. With $3.3B in annual revenue and a network of over 200 facilities, Surgery Partners remains a key player in the outpatient surgical market, but its ability to execute on operational improvements will be critical for sustaining growth.
What we're watching
- Operational Execution
- How Surgery Partners will address Q4 margin pressures and return to consistent growth in 2026.
- Higher-Acuity Shift
- The pace at which the company can successfully transition to higher-acuity procedures.
- Capital Allocation
- Whether the $200M share buyback program will be prioritized over strategic M&A or portfolio optimization.
Related topics